Better Therapeutics, Inc.
OTC: BTTX0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Craig R. Jalbert
- Employees
- 54
- Headquarters
- San Francisco, United States
- IPO year
- 2021
- Market cap
- $5.5K
- Website
- https://www.bettertx.com
Loading BTTX…
Loading profile data…Frequently asked questions about BTTX
What does Better Therapeutics, Inc. (BTTX) do?
Better Therapeutics, Inc., a prescription digital therapeutics company, develops a form of cognitive behavioral therapy to address the causes of cardiometabolic diseases. The company’s lead product candidate is BT-001, an investigational PDT platform to treat type 2 diabetes. It also develops software-based prescription digital therapeutics plat...
Where does BTTX trade?
Better Therapeutics, Inc. (BTTX) trades on the Other OTC.
What sector is BTTX in?
Better Therapeutics, Inc. (BTTX) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Better Therapeutics, Inc.?
Craig R. Jalbert is the chief executive officer of Better Therapeutics, Inc. (BTTX).
Where is Better Therapeutics, Inc. headquartered?
Better Therapeutics, Inc. is headquartered in United States.
Does BTTX pay a dividend?
Better Therapeutics, Inc. (BTTX) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did BTTX go public?
Better Therapeutics, Inc. (BTTX) completed its initial public offering in 2021.